Our office has moved to the 5th floor of the Crosstown Building located at 801 Massachusetts Avenue. We are no longer located in the Shapiro Building.

Boston Medical Center’s Office Based Addiction Treatment (OBAT) Program was established in 2003 and currently serves over 800 patients, making it the largest hospital-based addiction treatment program in New England. The OBAT team treats patients with approved medications for substance use disorders including buprenorphine, injectable buprenorphine, injectable naltrexone, and oral naltrexone. Patients receive specialized treatment for their substance use disorder integrated within a primary care setting, allowing all their medical needs to be addressed by a team of providers. The OBAT Program has been recognized nationally and replicated within many outpatient settings, including primary care, family medicine, behavioral health, and OB/Gyn practices, among others.

Click here for resources and virtual supports during COVID-19 pandemic

Derrek Anderson speaks about how the program helped him end 30 years of heroin use.

 

Contact Us

801 Massachusetts Ave Boston, MA 02119
Crosstown Center
617.414.4123
Monday - Thursday 8:00 AM - 8:00 PM; Friday 8:00 AM - 12:00 PM

Treatments & Services

The BMC OBAT Program provides the following services to patients:
  • Treatment for all types of Substance Use Disorders, including opioid, alcohol, benzodiazepine, and stimulant use disorders
  • Trained addiction experts including nurses, physicians, nurse practitioners, social workers, psychiatrists, patient care coordinators, medical assistants, and recovery coaches
  • Medications for Opioid Use Disorder (MOUD): buprenorphine (Suboxone), injectable buprenorphine (Sublocade), and naltrexone (Vivitrol, Revia)
  • Same-day medication access
  • Direct telephone access to the nursing team
  • Compassionate and non-judgmental care
  • Harm reduction services and resources
  • Specialized services to justice-involved individuals, adolescents, pregnant and post-partum women, and those with brain injuries
  • Assistance accessing social supports and other benefits (e.g., food, IDs, employment, insurance)
  • Behavioral health and psychiatric services
  • Access to short- and long-term birth control
  • Screening and treatment options for HIV; Hepatitis A, B, and C; and Sexually Transmitted Infections (STI)    
  • Overdose education and access to naloxone (Narcan)

Our Team

Program Leadership

Colleen Labelle, MSN, RN-BC, CARN
Program Director

Jason Worcester, MD
Medical Director

Lexie Bergeron, MPH, LCSW
Director of Operations

Nurse Care Manager Team

Christie Conners, BSN, RN
Nurse Care Manager

Stacey Dobrowolski, BSN, RN, CARN
Nurse Care Manager

Eileen Grassie, BSN, RN
Nurse Care Manager

Darlene Justal, BSN, RN
Nurse Care Manager

Michelle Lima, BSN, RN, CARN
Nurse Care Manager

Sarah McKeon, BSN, RN
Nurse Care Manager

Carla Merlos, BSN, RN
Nurse Care Manager

Jill Shaw, RN, CARN
Nurse Care Manager

Isela Wellington, BSN, RN
Nurse Care Manager

Susan Dickerman
Patient Care Coordinator

Chris Kennedy
Patient Care Coordinator

Antoneta Zyba
Medical Assistant

Stacey Mitchell
OBAT Triage Coordinator

Stimulant Treatment and Recovery Team (START)

Marielle C Baldwin, MD, MPH
Medical Director, START 

Meghan Brett, LICSW
Behavioral Health Group Clinician 

Anne Claude, BSN, RN
Nurse Care Manager, START

Sarah McKeon, BSN, RN
Nurse Care Manager, START 

Logan Puleikis
Program Coordinator, START

Shay Rainey
Patient Navigator, START

Dyana Salas, BSN, RN
Nurse Care Manager, START

Stephanie Taormina, MD
Psychiatrist

Alyssa Tilhou, MD
Medical Provider

Rachel Xue
Data Coordinator

Medical Prescribers

Daniel Alford, MD, MPH
Physician, OBAT

Jonathan P Berz, MD
Physician, OBAT

Joseph F Boyle, MD
Physician, OBAT

Robert D Bruce, MD
Physician, OBAT

Pablo A Buitron de la Vega, MD
Physician, OBAT

Sheila E Chapman, MD
Physician, OBAT

Shaleen Chakyayil, MD
Physician, OBAT

Chloe Ciccariello, MD
Physician, OBAT

Ricardo Cruz, MD
Physician, OBAT

Amy Fitzpatrick, MD
Physician, OBAT

Elke P Ganz, NP
Nurse Practitioner, OBAT

Sandra S Looby-Gordon, MD
Physician, OBAT

Alice Grant, FNP-C, MSN
Nurse Practitioner, OBAT

Emily E Hurstak, MD, MPH
Physician, OBAT

Theresa W Kim, MD
Physician, OBAT

Sarah L Kimball, MD
Physician, OBAT

Andrea Jodat, NDP, FNP-BC
Nurse Practitioner, OBAT

Jordana Laks, MD, MPH
Physician, OBAT

Karen E Lasser, MD
Physician, OBAT

Kristin Lee, MD
Physician, OBAT

Vasudev C Mandyam, MD
Physician, OBAT

Juhee C McDougal, MD
Physician, OBAT

Christine A Pace, MD
Physician, OBAT

Susan L Phillips, MD
Physician, OBAT

Annie L Potter, MSN, MPH, NP
Nurse Practitioner, OBAT

Christine A Prifti, MD
Physician, OBAT

Catherine A Rich, MD
Physician, OBAT

Margot P Rogers, MD
Physician, OBAT

Jeffrey H Samet, MD, MA, MPH
Physician, OBAT

Lucy B Shulson, MD
Physician, OBAT

Jennifer R Siegal, MD
Physician, OBAT

Jessica L Taylor, MD
Physician, OBAT

Kristin F Wason, MSN, NP-C
Nurse Practitioner, OBAT

Zoe M Weinstein, MD
Physician, OBAT

Theresa C Weir, NP
Nurse Practitioner, OBAT

 

Provider Resources

Training and Technical Assistance

BMC's OBAT Training and Technical Assistance (TTA) team supports over 40 community health centers across Massachusetts and advises health care teams locally and nationwide on how to implement this model of addiction treatment, now known as the Massachusetts Model, in their own organizations. 

Research Overview

Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness - Fine DR, Lewis E, Weinstock K, Wright J, Gaeta JM, Baggett TP. [published correction appears in JAMA Netw Open. 2021 Aug 2;4(8):e2128112]. JAMA Netw Open. 2021;4(3):e210477. Published 2021 Mar 1. doi:10.1001/jamanetworkopen.2021.0477

Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. - Weinstein ZM, Gryczynski G, Cheng DM, et al. Drug Alcohol Depend. 2018;189:166-171. doi:10.1016/j.drugalcdep.2018.05.010

Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse - Wason K, Potter A, Alves J, et al. . J Nurs Adm. 2021;51(9):424-429. doi:10.1097/NNA.0000000000001041

Residency and Fellowship Information

Addiction Medicine Fellowship

The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability or stigmatizing illness.

The Grayken Addiction Medicine Fellowship Program is a 1 or 2 year fellowship. There is also a 3-year combined Infectious Disease-Addiction Medicine Fellowship and a 2-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. Click here to learn more

Latest from HealthCity